Jan Wald
Jan Wald
actions company eventually expenses given remain stay
I think there are some actions the company will have to take and some expenses the company will have to incur that will make it tough. I still think given those parameters, it can be, stay and remain an independent company and eventually flourish.
actions louder speak
This is one of those times when actions speak louder than words.
company hard indication processes
It is another indication that the processes could have been better ? but the company is working hard on it already.
growth jude needs people thinking walk
J&J needs something like Guidant to revitalize its growth. People are now thinking that if J&J does walk away, St. Jude is in their scopes.
needs
J&J needs something like Guidant to revitalize its growth,
hard people work
People are Guidant's most important asset, ... so there are hard trade-offs for Guidant to work through.
boston buying good insider investors scientific
I think investors do take insider buying as a good sign, and I think they especially wanted Boston Scientific to do it.
appears doctors faster fresh good perhaps portion willing
It appears that a good portion of doctors are willing to give Guidant a fresh look in their practices, and perhaps faster than most believed.
time
But that is an awfully long time to look out for pharmaceuticals.
feeling
I have a feeling that Temecula is pretty safe.
along believe boston deal matter small strategic
I don't believe these things are going to matter for Boston Scientific. This is a strategic deal for them and these are small perturbations along the way.
boston deal power reach scientific
Boston Scientific will do everything in its power to reach a deal with Guidant.
boston company fda gain permit product quality saying scientific seemed until
What the FDA seemed to be saying is that it doesn't know if Boston Scientific has a systemic, corporate-wide quality policy, and until it does the FDA will not permit the company to gain product approvals in adulterated plants.
acquire growth investors rate
My sense is J&J is going to have to acquire to get a growth rate that investors will think is respectable.